The GLP-1 Agonist, Liraglutide, Ameliorates Inflammation Through the Activation of the PKA/CREB Pathway in a Rat Model of Knee Osteoarthritis
Journal of Inflammation - United Kingdom
doi 10.1186/s12950-019-0218-y
Full Text
Open PDFAbstract
Available in full text
Date
June 6, 2019
Authors
Publisher
Springer Science and Business Media LLC